Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-12-06
2005-12-06
Helms, Larry R. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S387100, C530S387300, C530S387900
Reexamination Certificate
active
06972323
ABSTRACT:
Anti-Fas antibodies which are cross-reactive with mouse and human Fas and are useful in the treatment of conditions attributable to abnormalities in the Fas/Fas ligand system.
REFERENCES:
patent: 5620889 (1997-04-01), Lynch et al.
patent: 0799891 (1997-10-01), None
patent: 0842948 (1998-05-01), None
patent: 0909816 (1999-04-01), None
patent: 0866131 (1999-09-01), None
patent: 10-165178 (1998-06-01), None
patent: 10-194989 (1998-07-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 95/10540 (1995-04-01), None
patent: WO 95/18819 (1995-07-01), None
patent: WO-9620206 (1996-07-01), None
patent: WO 96/40041 (1996-12-01), None
patent: WO 97/18307 (1997-05-01), None
Hartwig et., Blood vol. 99, pp. 3041-3049.
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
Green et al (May 1994, Nature Genetics, vol. 7, pp. 13-21.
Watanabe-Fukunaga et al (Feb. 15, 1992, The Journal of Immunology, vol. 148, p. 1274-1279).
Forre et al (2000, Scand J Rheumatol vol. 29, pp. 73-84).
T. Sumida et al, “3. Rheumatoid Arthritis and Apoptosis”,Internal Medicine,vol. 37, No. 2, pp. 184-188 (Feb. 1998).
K. Fujisawa et al, “Therapeutic Effect of the Anti-Fas Antibody on Arthritis in HTLV-I tax Transgenic Mice”,J. Clin. Invest.,vol. 98, No. 2, pp. 271-278 (Jul. 1996).
Y. Nishimura-Morita et al, “Amelioration of Systemic Autoimmune Disease by the Stimulation of Apoptosis-promoting Receptor Fas with Anti-Fas mAb”,International Immunology,vol. 9, No. 12, pp. 1793-1799 (1997).
U.S. Appl. No. 10/785,806, filed Feb. 24, 2004.
U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, “Sequences of Proteins of Immunological Interest”, vol. 1, Fifth Edition (1991), 118, 310.
Eiji Mita, Norio Hayashi, Sadaharu Iio, Tetsuo Takehara, Taizo Hijioka, Akinori Kasahara, Hideyuki Fusamoto and Takenobu Kamada, “Role of Fas Ligand in Apoptosis Induced by Hepatitis C Virus Infection”,Biochemical and Biophysical Research Communications, 204,468-474 (1994).
Toshihiro Nakajima, Hiroyuki Aono, Tomoko Hasunuma, Kazuhiko Yamamoto, Toshikazu Shirai, Kazushi Hirohata and Kusuki Nishioka, “Apoptosis and Functional Fas Antigen in Rheumatoid Arthritis Synoviocytes”,Arthritis&Rheumatism, 38,485-491 (1995).
Naoki Hiramatsu, Norio Hayashi, Kazuhiro Katayama, Kiyoshi Mochizuki, Yuko Kawanishi, Akinori Kashara, Hideyuki Fusamoto and Takenobu Kamada, “Immunohistochemical Detection of Fas Antigen in Liver Tissue of Patients with Chronic Hepatitis C”,Hepatology, 19,1354-1359 (1994).
Jeffrey M. Isner, Marianne Kearney, Scott Bortman, Jonathan Passeri, “Apoptosis in Human Atherosclerosis and Restenosis”,Circulation, 91,2703-2711 (1995).
Shin Yonehara, Ai Ishii, and Minako Yonehara, “A Cell-Killing Monoclonal Antibody (ANTI-Fas) To a Cell Surface Antigen Co-Downregulated with the Receptor of Tumor Necrosis Factor”,J. Exp. Med, 169,1747-1756 (1989).
F. Rieux-Laucat, F. Le Deist, C. Hivroz, I.A.G. Roberts, K.M. Debatin, A. Fischer, J.P. de Villartay, “Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity”,Science, 268,1347-1349 (1995).
Bruce Richardson, Narendra Lalwani, Kent Johnson and Rory Marks, “Fas Ligation Triggers Apoptosis in Macrophages But Not Endothelial Cells”,Eur. J. Immunol., 24,2640-2645 (1994).
Akira Shimizu, Hiroshi Kitamura, Yukinari Masuda, Masamichi Ishizaki, Yuichi Sugisaki, and Nobuaki Yamanaka, “Apoptosis in the Repair Process of Experimental Proliferative Glomerulonephritis”,Kidney International, 47,114-121 (1995).
Jaroslaw Maciejewski, Carmine Selleri, Tadatsugu Sato, Stacie Anderson and Neal Young, “Increased Expression of Fas Antigen on Bone Marrow CD34+Cells of Patients with Aplastic Anaemia”,British Journal of Haematology, 91,245-252 (1995).
Tsukasa Takemura, Katsumi Murakami, Hirofumi Miyazato, Kazuro Yagi, and Kazuo Yoshioka, “Expression of Fas antigen and Bcl-2 in Human Glomerulonephritis”,Kidney International, 48,1886-1892 (1995).
Hitoshi Sugiyama, Naoki Kashihara, Hirofumi Makino, Yasushi Yamasaki and Zensuke OTA, “Apoptosis in Glomerular Sclerosis”,Kidney International, 49,103-111 (1996).
Jun Ogasawara, Rie Watanabe-Fukunaga, Masashi Adachi, Akio Matsuzawa, Tsutomu Kasugai, Yukihiko Kitamura, Naoto Itoh, Takashi Suda, and Shigekazu Nagata, “Lethal Effect of the Anti-Fas Antibody in Mice”,Nature, 364,806-809 (1993).
Laurie Owen-Schaub, Shin Yonehara, William Crump III, and Elizabeth Grimm, “DNA Fragmentation and Cell Death is Selectively Triggered in Activated Human Lymphocytes by Fas Antigen Engagement”,Cellular Immunology, 140,197-205 (1992).
Amanda Baker, Andrew Mooney, Jeremy Hughes, Donna Lombardi, Richard Johnson and John Savill, “Mesangial Cell Apoptosis: The Major Mechanism for Resolution of Glomerular Hypercellularity in Experimental Mesangial Proliferative Nephritis”,J. Clin. Invest, 94,2105-2116 (1994).
Peter Galle, Walter Hofmann, Hennign Walczak, Heinz Schaller, Gerd Otto, Wolfgang Stremmel, Peter Krammer and Laura Runkel, “Involvement of the CD95 (APO-1/Fas) Receptor and Ligand in Liver Damage”,J. Exp. Med., 182,1223-1230 (1995).
Toru Kondo, Takashi Suda, Hidehiro Fukuyama, Masashi Adachi and Shigekazu Nagata, “Essential Roles of the Fas Ligand in the Development of Hepatitis”,Nature Medicine, 3,409-413 (1997).
Andreas Strasser, “Death of a T cell”,Nature, 373,385-386 (1995).
Galen Fisher, Fredric Rosenberg, Stephen Straus, Janet Dale, Lindsay Middelton, Albert Lin, Warren Strober, Michael Lenardo, Jennifer Puck, “Dominant Interfering Fas Gene Mutations Impair Apoptosis in a Human Autoimmune Lymphoproliferative Syndrome”,Cell, 81,935-946 (1995).
Jia Li Chu, Paula Ramos, Adam Rosendorff, Jako Nikolic-Zugic, Elizabeth Lacy, Akio Matsuzawa and Keith Elkon, “Massive Upregulation of the Fas Ligand in lpr and gld Mice: Implications for Fas Regulation and the Graft-versus-Host Disease-like Wasting Syndrome”,J. Exp. Med., 181,393-398 (1995).
Shogo Tsuyuki, Claude Bertrand, Francois Erard, Alexandre Trifilieff, Junko Tsuyuki, Martin Wesp, Gary Anderson and Anthony Coyle, “Activation of the Fas Receptor on Lung Eosinophils Leads to Apoptosis and the Resolution of Eosinophilic Inflammation of the Airways”,J. Clin. Invest., 96,2924-2931 (1995).
Michael Sneller, Stephen Straus, Elaine Jaffe, Jonathan Jaffe, Thomas Fleisher, Maryalice Stetler-Stevenson and Warren Strober, “A Novel Lymphoproliferative/Autoimmune Syndrome Resembling Murine lpr/gld Disease”,J. Clin. Invest, 90,334-341 (1992).
Tran Thi Minh Hoa, Tomoko Hasunuma, Hiroyuki Aono, Kayo Masuko, Tetsuji Kobata, Kazuhiko Yamamoto, Takayuki Sumida and Kusuki Nishioka, “Novel Mechanisms of Selective Apoptosis in Synovial T Cells of Patients with Rheumatoid Arthritis”,The Journal of Rheumatology, 23,1332-1337 (1996).
J.F.R. Kerr, A.H. Wyllie and A.R. Currie, “Apoptosis: A Basic Biological Phenomenon with Wide-Ranging Implications in Tissue Kinetics”,Br. J. Cancer, 26,239-257 (1972).
R.H.J. Begent et al., “Phase I/II Study of Chimeric B72.3 Antibody in Radioimmunoassay of Colorectal Cancer”,Br. J. Cancer, 62474 and 487 (1990).
Sherie Morrison, M. Jacqueline Johnson, Leonard Herzenberg, and Vernon Oi, “Chimeric Human Antibody Molecules: Mouse Antigen-binding Domains with Human Constant Region Domains”,Proc. Natl. Acad. Sci. USA, 81,6851-6855 (1984).
Peter Jones, Paul Dear, Jefferson Foote, Michael Neuberger and Greg Winer, “Replacing the Complementarity-determining Regions in a Human Antibody With Those From a Mouse”,Nature, 321,522-525 (1986).
Robert Schroff, Kenneth Foon, Shannon Beatty, Robert Oldham and Alton Morgan, Jr., “Human Anti-Murine Immunoglobulin Responses in Patients Receiving Monoclonal Antibod
Haruyama Hideyuki
Ichikawa Kimihisa
Ohsumi Jun
Ohtsuki Masahiko
Serizawa Nobufusa
Frishauf Holtz Goodman & Chick P.C.
Helms Larry R.
Sankyo Company Limited
Yu Misook
LandOfFree
Anti-Fas antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-Fas antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-Fas antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3490340